Successful Transformation of Foreign Headquarters in Shanghai: L'Oréal Collaborates with Chinese Enterprise to Win International Award, Products Rapidly Selling in Over 20 Countries!
A beauty device incorporating Chinese semiconductor innovation—the Lancôme Rénergie Nano Resurfacer—won the "Best Innovation Award" in the Beauty Tech category at the 2026 Consumer Electronics Show held in the U.S. earlier this month.
In addition to industry recognition, it has quickly gained market acceptance. The product made its global debut only two months ago at the 8th China International Import Expo and is now available in over 20 countries, with plans to enter more international markets.
Why has this newly launched innovative product achieved both critical acclaim and commercial success? The answer lies in a co-creation model from Shanghai. Through its BIG BANG beauty tech co-creation program, L'Oréal China selected a biosemiconductor company with proprietary photolithography technology from hundreds of startups to co-develop the product with the brand, ultimately realizing the commercial application of the innovation.
As China's beauty industry accelerates, leading foreign companies with headquarters in Shanghai—such as L'Oréal, Clarins, and La Prairie—are resolutely transforming and upgrading in the face of intense market competition. They are evolving from traditional commercial entities focused on market management and product distribution into global innovation hubs integrating R&D, regional empowerment, and brand investment. By collaborating with upstream and downstream partners, they are enhancing the overall value of the industrial chain.
Over two decades ago, at the turn of the millennium, foreign beauty companies like L'Oréal entered the Chinese market, introducing consumers to beauty concepts and brand awareness. Today, China has become the world's largest cosmetics consumer market, entering a phase of trillion-scale development.
"The continuous expansion of the Chinese market is a core driver attracting foreign companies to increase their investment in China. In particular, the increasingly refined and personalized demands of domestic consumers urge international brands to accelerate the enhancement of local R&D capabilities." Driven by both market demand and local scientific research strength, the R&D centers of international beauty brands in China have achieved a dual leap in scale and capability in recent years.
Take L'Oréal as an example. The company established its China R&D center in Shanghai in 2005. After more than two decades of development, the center now employs approximately 400 R&D scientists, 75% of whom hold master's or doctoral degrees. It is one of L'Oréal's seven global R&D hubs and one of its three major beauty tech hubs. In 2024, L'Oréal generated 81 invention patents from its R&D in China. Since its inception, the China R&D center has developed over 300 new formulas tailored specifically for Chinese consumers.
With this enhanced capability, the R&D center's influence has expanded beyond its initial mission of serving the Chinese market. More and more innovations are going global, feeding back into the international market and creating a virtuous cycle of mutual empowerment.
For instance, a L'Oréal hyaluronic acid sheet mask, highly popular in European and American markets, was launched in 2017 thanks to Chinese-originated fit technology. Subsequently, the Chinese R&D team formally took over the global innovation development for sheet masks, establishing its global leadership in this field.
Today, even Chinese R&D talent is highly sought after in the global beauty industry. "Many employees from the China R&D center have gone on to become heads of L'Oréal's overseas R&D departments in countries like South Korea and France."
On one hand, as Shanghai serves as a global cosmetics headquarters hub, numerous internationally renowned cosmetics companies like L'Oréal, Clarins, and L'Occitane have established their China or regional headquarters here. On the other hand, Shanghai is home to top-tier medical institutions like Shanghai Skin Disease Hospital and Huashan Hospital's Dermatology Department, providing core support in research, clinical practice, and professional talent. Additionally, domestic beauty brands like Yoseido are emerging and growing here. L'Oréal has signed cooperation agreements with leading medical institutions such as Huashan Hospital affiliated with Fudan University and Shanghai Skin Disease Hospital. For example, the joint "Medical-Research Co-creation Dermatology Science Laboratory" with Huashan Hospital extends local R&D from within the company to an open, collaborative "industry-medical-research" network.
Data from the 2025 China Fragrance & Cosmetics Brand Development Conference shows that among the "2025 Top 50 Cosmetic Brands," 22 are Chinese brands, with total retail sales of 93.354 billion RMB, accounting for 39.98% of the top 50's total retail sales. China's domestic beauty industry is experiencing explosive growth, and "investing in China is investing in the future" has become a consensus among many foreign enterprises.
"In Shanghai, we see a tremendous number of unexpected new concepts, new products, and new stores that inspire and enlighten us." The L'Oréal Group is optimistic about China's local innovation capabilities. "We believe that China's beauty industry will experience limitless, vigorous development."
Many other foreign companies are going a step further, acting as talent scouts through co-creation models to cultivate local rising stars. For instance, the BIG BANG beauty tech co-creation program initiated by L'Oréal China focuses on cutting-edge fields like biotechnology and artificial intelligence. To date, it has attracted over 2,500 startups and SMEs and successfully incubated over 80 pilot projects. The biosemiconductor company involved in co-creating the Lancôme beauty device was a winner in the first edition of the competition. Its proprietary photolithography technology enabled the design of a unique chip for the beauty device, helping to control the delivery of cosmetic active ingredients into the superficial layers of the skin.
The BIG BANG model, originating in Shanghai, has now expanded to the South Asia, Pacific, Middle East, North Africa (SAPMENA) region, covering over 30 regional markets. The project not only promotes high-quality Chinese startups on global stages like France's VivaTech innovation exhibition but also helps promising overseas companies establish a presence in China. For example, CtiBiotech, a startup that won the French track, has signed a cooperation agreement with Shanghai's Oriental Beauty Valley, facilitating a two-way flow of innovative resources between China and abroad. In the past, the industry habitually looked to Europe and America for innovation direction. Now, the BIG BANG program acts as a lighthouse, guiding global attention towards China and highlighting the power of China's industrial innovation.